advertisement

---

Tribble JR 14

Showing records 1 to 14 | Display all abstracts from Tribble JR

119007 Glial metabolic alterations during glaucoma pathogenesis
Rombaut A
Frontiers in ophthalmology 2023; 3: 1290465

---

119792 Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma
Rombaut A
Molecular brain 2024; 17: 84

---

120162 Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Cimaglia G
Acta neuropathologica communications 2024; 12: 137

---

119792 Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma
Rombaut A
Molecular brain 2024; 17: 84

---

119007 Glial metabolic alterations during glaucoma pathogenesis
Rombaut A; Brautaset R
Frontiers in ophthalmology 2023; 3: 1290465

---

120162 Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Tribble JR
Acta neuropathologica communications 2024; 12: 137

---

119792 Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma
Brautaset R
Molecular brain 2024; 17: 84

---

119007 Glial metabolic alterations during glaucoma pathogenesis
Williams PA
Frontiers in ophthalmology 2023; 3: 1290465

---

120162 Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Votruba M
Acta neuropathologica communications 2024; 12: 137

---

119792 Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma
Williams PA
Molecular brain 2024; 17: 84

---

120162 Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Williams PA
Acta neuropathologica communications 2024; 12: 137

---

119007 Glial metabolic alterations during glaucoma pathogenesis
Tribble JR
Frontiers in ophthalmology 2023; 3: 1290465

---

119792 Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma
Tribble JR
Molecular brain 2024; 17: 84

---

120162 Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Morgan JE
Acta neuropathologica communications 2024; 12: 137

---